Jump to content
Crime Forum
FORUMS BLOG/NEWS USER BLOGS USER MEDIA ADVERTS   ADD  MANAGE CHAT CLUBS & USER'S PERSONAL FORUMS LINK EXCHANGE

Blogs

The ‘Patient Recruitment and Retention Services, 2019-2030{RootsAnalysis}

https://www.rootsanalysis.com/reports/view_document/patient-recruitment-and-retention-services-market-2019-2030/245.html   Key Inclusions §  A detailed assessment of the current market landscape, including information on drug developer(s), §  A detailed assessment of the current market landscape of companies offering patient recruitment and retention services, including information on over 10 types of patient outreach methods employed, types of services offered ([A] patient

Narender

Narender in Roots Analysis

Presently, close to 140 companies claim to be actively engaged in offering patient recruitment / retention services{Roots}

A steadily increasing demand for study participants and the complexities associated with patient enrollment has imposed a significant burden on drug developer companies, prompting them to enlist the services of specialty service providers. Presently, close to 140 companies are actively offering patient recruitment and retention services. Majority of these players possess vast service portfolios and utilize diverse patient outreach methods to recruit study participants across different geographie

Narender

Narender in Roots Analysis

The patient recruitment and retention services market is projected to grow at an annualized rate of ~5%<RootsAnalysis>

Roots Analysis has done a detailed study on Patient Recruitment and Retention Services Marker, 2019-2030.”, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 300+ page report, which features 90+ figures and 140+ tables, please visit this -https://www.rootsanalysis.com/reports/view_document/patient-recruitment-and-retention-services-market-2019-2030/245.html   Key Market Insights §  Presently, close to

Narender

Narender in Roots Analysis

The patient recruitment and retention services market is estimated to be worth USD 5.3 billion in 2030

A steadily increasing demand for participants in clinical research studies, coupled to the complexities associated with patient enrolment, have prompted drug / therapy developers to outsource this process to specialty service providers   Roots Analysis  is pleased to announce the publication of its recent study, titled, “Patient Recruitment and Retention Services Marker, 2019-2030.”   The report offers a comprehensive study of the current scenario and future potential of the

Narender

Narender in Roots Analysis

The “Cell Therapy Manufacturing Market (3rd Edition), 2019-2030<Roots>

https://www.rootsanalysis.com/reports/view_document/cell-therapy-manufacturing/285.html   Key Inclusions §  A detailed review of the overall landscape of companies that are engaged in the manufacturing of cell-based therapies, including information on the type of cells manufactured (including immune cells (including T cells, dendritic cells, NK cells), stem cells (including adult stem cells, human embryonic stem cells and induced pluripotent stem cells) and others), source of cell

Narender

Narender in Roots Analysis

More than 100 industry players and over 60 non-industry players currently claim to manufacture (RootsAnalysis)

Owing to various reasons, the demand for cell therapies is anticipated to increase over the coming years. Therefore, both therapy developers and contract service providers may need to strengthen their capabilities and expand available capacity. In this context, automation is expected to be a key enabler within the cell therapy manufacturing and contract services industry   To order this 550+ page report, which features 160+ figures and 250+ tables, please visit this - https://www.roots

Narender

Narender in Roots Analysis

The cell therapy manufacturing market is projected to grow at an annualized rate of >16.5%(Roots)

Roots Analysis has done a detailed study on Cell Therapy Manufacturing Market (3rd Edition), 2019 - 2030”, covering various important aspects of the industry and identifying key future growth opportunities.   To order this 550+ page report, which features 160+ figures and 250+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/cell-therapy-manufacturing/285.html   Key Market Insights §  More than 100 industry players and over 60 non-industry

Narender

Narender in Roots Analysis

The cell therapy manufacturing market is estimated to reach close to USD 11 Billion by 2030: By RootsAnalysis:

Manufacturing cell therapies is technically and financially demanding; as a result, despite therapy developers gradually strengthening their in-house expertise, they are also becoming increasingly reliant on contract service providers   Roots Analysis is pleased to announce the publication of its recent study, titled, “Cell Therapy Manufacturing Market (3rd Edition), 2019 - 2030”.”   The report features an extensive study of the current market landscape and future opportuniti

Narender

Narender in Roots Analysis

Growing at an annualized rate of over 16.5%, the cell therapy manufacturing market:By Roots:

The approval of KYMIRAH®, YESCARTA®, Alofisel® and Zyntelgo® has increased the interest of pharma stakeholders in cell therapies; further, owing to the technical challenges in this field, outsourcing manufacturing operations has become a necessity   Roots Analysis has announced the addition of “Cell Therapy Manufacturing Market (3rd Edition), 2019 - 2030” report to its list of offerings.   Owing to various reasons, the demand for cell therapies is anticipated to increase ove

Narender

Narender in Roots Analysis

More than 100 subcutaneous biologics have been approved and over 350 such drug candidates{Roots}

Several approved therapeutic products, which are currently available as intravenous dosage forms, are being reformulated and evaluated for subcutaneous administration. Further, many existing drug delivery devices, including prefilled syringes, pen injectors, autoinjectors, needle-free injectors and large volume wearable injectors, have been / are being designed for subcutaneous administration of biologics.   To order this 530+ page report, which features 160+ figures and 190+ tables, p

Narender

Narender in Roots Analysis

The subcutaneous biologic drugs and affiliated technologies market is projected to be worth over USD 180: By RootsAnalysis:

To order this 530+ page report, which features 160+ figures and 190+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/subcutaneous-biologics-delivery/314.html   Key Market Insights §   Eminent representatives from biopharmaceutical companies confirm the rising interest in the concept of subcutaneous drug delivery, highlighting some of the key drivers and upcoming trends in this domain §   More than 100 subcutaneous biologics have been approved

Narender

Narender in Roots Analysis

The subcutaneous biologic drugs and affiliated technologies market is projected to be worth over USD 180 billion by 2030: By Roots:

Subcutaneous drug delivery, given the use of tailored formulation development solutions, has brought about a paradigm shift in at-home healthcare, enabling users to administer (life-saving) medications without having to rely on medical professionals   Roots Analysis is pleased to announce the publication of its recent study, titled “Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030” report to its list of offerings.   The report provides

Narender

Narender in Roots Analysis

The “Medical Device Labels Manufacturing Market, 2019-2030(RootsAnalysis)

https://www.rootsanalysis.com/reports/view_document/medical-device-labels-manufacturing-market-2019-2030/272.html   Key Inclusions §  A detailed review of the overall landscape of companies offering manufacturing services for medical device labels, along with information on location of headquarters, year of establishment, company size, details related to regulatory certification / accreditation, types of label printing technologies used (digital, flexographic, screen, foil stampin

Narender

Narender in Roots Analysis

More than 80 companies presently claim to have the required expertise to design and manufacture(Roots)

Owing to the ever-increasing number of medical devices along with the rising associated complexities and stringent guidelines issued by various regulatory authorities, the global medical device labeling market is likely to grow at stable rate. Furthermore, it is also necessary for the organizations to adopt labeling practices which can help them to reduce reaction time in order to process change requirements. Therefore, in order to overcome the aforementioned challenges, medical devices companie

Narender

Narender in Roots Analysis

The medical device label contract manufacturing market is projected to grow at an annualized rate of ~9.8%:By RootsAnalysis:

Roots Analysis has done a detailed study on “Medical Device Labels Technology Market, 2019-2030 covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 300+ page report, which features 150+ figures and 140+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/medical-device-labels-manufacturing-market-2019-2030/272.html   Key Market Insights §  More than 80 companies presently cla

Narender

Narender in Roots Analysis

The medical device label contract manufacturing market is projected to reach USD 509 million in 2030 : By Roots:

Roots Analysis has announced the addition of “Medical Device Labels Technology Market, 2019-2030” report to its list of offerings.   The report features an extensive study of the current market landscape of companies offering manufacturing services for medical device labels. The study also features detailed analysis and an elaborate discussion on the future potential of this evolving market. Amongst other elements, the report includes: §  A detailed assessment of the overall land

Narender

Narender in Roots Analysis

The “Oligonucleotide Synthesis, Modification and Purification Services Market{RootsAnalysis}

https://www.rootsanalysis.com/reports/view_document/oligonucleotide-synthesis/304.html   Key Inclusions §  A detailed review of the current status of the market with respect to oligonucleotide manufacturers focused on research and diagnostic, and therapeutic applications. It features information on the year of establishment, company size, scale of operation (preclinical, clinical, and commercial), location of headquarters, number of manufacturing facilities, along with their locat

Narender

Narender in Roots Analysis

More than 80 companies currently claim to offer manufacturing related services{Roots}

Several big pharma companies are known to outsource more than half of their clinical-stage oligonucleotide manufacturing operations. Anticipating a sharp rise in demand, oligonucleotide manufacturers are increasingly consolidating their portfolios, building new capabilities and expanding their respective capacities, mostly through acquisitions, in order to gain a competitive edge.   To order this 300+ page report, which features 140+ figures and 190+ tables, please visit this - https:/

Narender

Narender in Roots Analysis

The oligonucleotide synthesis, modification and purification services market :By RootsAnalysis:

Roots Analysis has done a detailed study on “Oligonucleotide Synthesis, Modification and Purification Services Market: Focus on Research, Diagnostic and Therapeutic Applications, 2020-2030.”” covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 300+ page report, which features 140+ figures and 190+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/oligonucleotide-synthesis/304.html  

Narender

Narender in Roots Analysis

The oligonucleotide synthesis, modification and purification services market :By Roots:

The applications of oligonucleotides are vast, even beyond the life science / pharma sector; however, owing to complexities associated with the synthesis and processing of these molecules, such operations are usually outsourced to capable CMOs   Roots Analysis is pleased to announce the publication of its recent study, titled, “Oligonucleotide Synthesis, Modification and Purification Services Market: Focus on Research, Diagnostic and Therapeutic Applications, 2020-2030.”   T

Narender

Narender in Roots Analysis

The “HPAPI and Cytotoxic Drugs Manufacturing Market (3rd Edition), 2020-2030(RootsAnalysis)

https://www.rootsanalysis.com/reports/view_document/hpapi-and-cytotoxic-drugs-manufacturing/299.html   Key Inclusions §  A detailed review of the overall landscape of companies offering contract services for the manufacturing of HPAPIs and cytotoxic drugs, along with information on year of establishment, company size, scale of operation (preclinical, clinical and commercial), location of headquarters, number and location of manufacturing facilities, facility size, type of service(

Narender

Narender in Roots Analysis

Close to 120 companies across the globe claim to possess the required expertise and infrastructure(Roots)

Development initiatives of HPAPIs and cytotoxic drugs are generally very demanding, both in terms of experience and capital investment. Most companies generally lack the necessary resources to meet the aforementioned requirements and are unable to set up dedicated HPAPI and cytotoxic drug manufacturing facilities. This has led to an increased demand for contract manufacturing service providers in this field.   To order this 300+ page report, which features 75+ figures and 150+ tables,

Narender

Narender in Roots Analysis

Growing at an annualized rate of 12%, the HPAPI and cytotoxic drugs contract manufacturing market By:RootsAnalysis:

Roots Analysis has done a detailed study on “HPAPI and Cytotoxic Drugs Manufacturing (3rd Edition) 2020-2030”, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 300+ page report, which features 75+ figures and 150+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/hpapi-and-cytotoxic-drugs-manufacturing/299.html   Key Market Insights §  Close to 120 companies across the g

Narender

Narender in Roots Analysis

×
  • Create New...